SPON1 is an independent prognostic biomarker for ovarian cancer

• Main Authors: Ryoya Miyakawa (Author), Makoto Kobayashi (Author), Kotaro Sugimoto (Author), Yuta Endo (Author), Manabu Kojima (Author), Yasuyuki Kobayashi (Author), Shigenori Furukawa (Author), Tsuyoshi Honda (Author), Takafumi Watanabe (Author), Shigeyuki Asano (Author), Shu Soeda (Author), Yuko Hashimoto (Author), Keiya Fujimori (Author), Hideki Chiba (Author)
• Format: Book
• Published: BMC, 2023-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Ovarian cancer has the worst outcome among gynecological malignancies; therefore, biomarkers that could contribute to the early diagnosis and/or prognosis prediction are urgently required. In the present study, we focused on the secreted protein spondin-1 (SPON1) and clarified th...